Pharmacological profiles and therapeutic applications of pachymic acid (Review)
- Authors:
- Chunyong Wei
- Hezhen Wang
- Xun Sun
- Zhixun Bai
- Jing Wang
- Guohui Bai
- Qizheng Yao
- Yingshu Xu
- Lei Zhang
-
Affiliations: Key Laboratory of Basic Pharmacology of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Key Laboratory of Basic Pharmacology of Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Department of Internal Medicine, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Key Laboratory of Oral Disease Research, School of Stomatology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China - Published online on: July 1, 2022 https://doi.org/10.3892/etm.2022.11484
- Article Number: 547
-
Copyright: © Wei et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Li J, Wang Y, Xue J, Wang P and Shi S: Dietary exposure risk assessment of flonicamid and its effect on constituents after application in lonicerae japonicae flos. Chem Pharm Bull (Tokyo). 66:608–611. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Shingu T, Tai T and Akahori A: A lanostane triterpenoid from Poria cocos. Phytochemistry. 31:2548–2549. 1992. | |
|
Zheng Y and Yang XW: Two new lanostane triterpenoids from Poria cocos. J Asian Nat Prod Res. 10:323–328. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Dong HJ, Xue ZZ, Geng YL, Wang X and Yang B: Lanostane triterpenes isolated from epidermis of Poria cocos. Phytochem Lett. 22:102–106. 2017. | |
|
Ríos JL: Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 77:681–691. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Zhao YY, Feng YL, Du X, Xi ZH, Cheng XL and Wei F: Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J Ethnopharmacol. 144:775–778. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Nie A, Chao Y, Zhang X, Jia W, Zhou Z and Zhu C: Phytochemistry and pharmacological activities of WolfiPoria cocos (FA Wolf) Ryvarden & Gilb. Front Pharmacol. 11(505249)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Tian J, Zhou L, Meng L, Chen S, Ma C, Wang J, Liu Z, Li C and Kang W: Phytochemistry and Biological Activities of Poria. J Chem. 2021(6659775)2021. | |
|
Lai KH, Lu MC, Du YC, El-Shazly M, Wu TY, Hsu YM, Henz A, Yang JC, Backlund A, Chang FR and Wu YC: Cytotoxic Lanostanoids from Poria cocos. J Nat Prod. 79:2805–2813. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Taofiq O, Martins A, Barreiro MF and Ferreira ICFR: Anti-inflammatory potential of mushroom extracts and isolated metabolites. Trends Food Sci Tech. 50:193–210. 2016. | |
|
Tang X, Chen J and Shen X: The signaling pathway for regulation of glucose transporter 4 and its application in drug devel-opment. Sci Sin Chim. 42:1760–1773. 2012. | |
|
Wu Z, Chen X, Ni W, Zhou D, Chai S, Ye W, Zhang Z, Guo Y, Ren L and Zeng Y: The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: A network pharmacology and molecular docking study. RSC Adv. 11:11821–11843. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Shah VK, Choi JJ, Han JY, Lee MK, Hong JT and Oh KW: Pachymic acid enhances pentobarbital-induced sleeping be-haviors via GABAA-ergic systems in mice. Biomol Ther (Seoul). 22:314–320. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Pang Y, Zhu S and Pei H: Pachymic acid protects against cerebral ischemia/reperfusion injury by the PI3K/Akt signaling pathway. Metab Brain Dis. 35:673–680. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tai T, Shingu T, Kikuchi T, Tezuka Y and Akahori A: Isolation of lanostane-type triterpene acids having an acetoxyl group from sclerotia of Poria cocos. Phytochemistry. 40:225–231. 1995. | |
|
Li G, Xu ML, Lee CS, Woo MH, Chang HW and Son JK: Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch Pharm Res. 27:829–833. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Akihisa T, Nakamura Y, Tokuda H, Uchiyama E, Suzuki T, Kimura Y, Uchikura K and Nishino H: Triterpene acids from Poria cocos and their anti-tumor-promoting effects. J Nat Prod. 70:948–953. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Zhou L, Zhang Y, Gapter LA, Ling H, Agarwal R and Ng KY: Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos. Chem Pharm Bull (Tokyo). 56:1459–1462. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Cai TG and Cai Y: Triterpenes from the fungus Poria cocos and their inhibitory activity on nitric oxide production in mouse macrophages via blockade of activating protein-1 pathway. Chem Biodivers. 8:2135–2143. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Yang H, Shen Y, Chen B, Jia X and Cai B: RP-HPLC-DAD determination of six triterpenes in a herbal tonic hoelen. J Liq Chromatogr Relat Technol. 34:1772–1782. 2011. | |
|
Li S, Wang Z, Gu R, Zhao Y, Huang W, Wang Z and Xiao W: A new epidioxy-tetracyclic triterpenoid from Poria cocos Wolf. Nat Prod Res. 30:1712–1717. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Wang GZ, Nie L and Shen JY: Study on the content comparison of pachymic acid from different medicinal parts of Poria cocos (Schw.) Wolf. Lishizhen Med Mater Med Res. 26:2858–2860. 2015. | |
|
Fu M, Wang L, Wang X, Deng B, Hu X and Zou J: Determination of the five main terpenoids in different tissues of WolfiPoria cocos. Molecules. 23(1839)2018.PubMed/NCBI View Article : Google Scholar | |
|
Yang PF, Hua T, Wang D, Zhao ZW, Xi GL and Chen ZF: Phytochemical and chemotaxonomic study of Poria cocos (Schw.) Wolf. Biochem Syst Ecol. 83:54–56. 2019. | |
|
Jiang TT, Ding LF, Nie W, Wang LY, Lei T, Wu XD and Zhao QS: Tetranorlanostane and lanostane triterpenoids with cytotoxic activity from the epidermis of Poria cocos. Chem Biodivers. 18(e2100196)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kim TG, Lee YH, Lee NH, Bhattarai G, Lee IK, Yun BS and Yi HK: The antioxidant property of pachymic acid improves bone disturbance against AH Plus-induced inflammation in MC-3T3 E1 cells. J Endod. 39:461–466. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Lee YH, Lee NH, Bhattarai G, Kim GE, Lee IK, Yun BS, Hwang PH and Yi HK: Anti-inflammatory effect of pachymic acid promotes odontoblastic differentiation via HO-1 in dental pulp cells. Oral Dis. 19:193–199. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Keller AC, Maillard MP and Hostettmann K: Antimicrobial steroids from the fungus Fomitopsis pinicola. Phytochemistry. 41:1041–1046. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Kuo PC, Tai SH, Hung CC, Hwang TL, Kuo LM, Lam SH, Cheng KC, Kuo DH, Hung HY and Wu TS: Anti-inflammatory triterpenoids from the fruiting bodies of Fomitopsis pinicola. Bioorg Chem. 108(104562)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ma J, Liu J, Lu CW and Cai DF: Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3. Int J Clin Exp Pathol. 8:5464–5470. 2015.PubMed/NCBI | |
|
Zhu W, Liu Y, Tang J, Liu H, Jing N, Li F, Xu R and Shu S: Functional analysis of sterol O-Acyltransferase involved in the biosynthetic pathway of pachymic acid in WolfiPoria cocos. Molecules. 27(143)2021.PubMed/NCBI View Article : Google Scholar | |
|
Cai SY, Lv SW, Wang YH, Guo YY and Li YJ: Solubility and Apparent Oil/Water Partition Coefficient of Glycyrrhizin and Pachymic Acid. Inf Tradit Chin Med. 29:118–121. 2012.(In Chinese). | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Xu H, Wang Y, Zhao J, Jurutka PW, Huang D, Liu L, Zhang L, Wang S, Chen Y and Cheng S: Triterpenes from Poria cocos are revealed as potential retinoid X receptor selective agonists based on cell and in silico evidence. Chem Biol Drug Des. 95:493–502. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jeong JW, Baek JY, Kim KD, Choi YH and Lee JD: Induction of apoptosis by pachymic acid in T24 human bladder cancer cells. J Life Sci. 25:93–100. 2015. | |
|
Jeong JW, Lee WS, Go SI, Nagappan A, Baek JY, Lee JD, Park C, Kim GY, Kim HJ, Kim GS, et al: Pachymic acid induces apoptosis of EJ bladder cancer cells by DR5 up-regulation, ROS generation, modulation of Bcl-2 and IAP family members. Phytother Res. 29:1516–1524. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang YH, Zhang Y, Li XY, Feng XD, Jian W and Li RQ: Antitumor activity of the pachymic acid in nasopharyngeal carcinoma cells. Ultrastruct Pathol. 41:245–251. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Gapter L, Wang Z, Glinski J and Ng KY: Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun. 332:1153–1161. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wen H, Wu Z, Hu H, Wu Y, Yang G, Lu J, Yang G, Guo G and Dong Q: The anti-tumor effect of pachymic acid on osteosarcoma cells by inducing PTEN and Caspase 3/7-dependent apoptosis. J Nat Med. 72:57–63. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Miao G, Han J, Zhang J, Wu Y and Tong G: Targeting pyruvate kinase M2 and Hexokinase II, pachymic acid impairs glucose metabolism and induces mitochondrial apoptosis. Biol Pharm Bull. 42:123–129. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Jiang Y and Fan L: Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism. J Ethnopharmacol. 257(112851)2020.PubMed/NCBI View Article : Google Scholar | |
|
Ling H, Jia X, Zhang Y, Gapter LA, Lim YS, Agarwal R and Ng KY: Pachymic acid inhibits cell growth and modulates arachidonic acid metabolism in nonsmall cell lung cancer A549 cells. Mol Carcinog. 49:271–282. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Ma J, Liu J, Lu C and Cai D: Pachymic acid induces apoptosis via activating ROS-dependent JNK and ER stress pathways in lung cancer cells. Cancer Cell Int. 15(78)2015.PubMed/NCBI View Article : Google Scholar | |
|
Sun KX and Xia HW: Pachymic acid inhibits growth and induces cell cycle arrest and apoptosis in gastric cancer SGC-7901 cells. Oncol Lett. 16:2517–2524. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Lu C, Ma J and Cai D: Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway. Anticancer Drugs. 28:170–179. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Cheng S, Swanson K, Eliaz I, McClintick JN, Sandusky GE and Sliva D: Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress. PLoS One. 10(e0122270)2015.PubMed/NCBI View Article : Google Scholar | |
|
Kaminaga T, Yasukawa K, Kanno H, Tai T, Nunoura Y and Takido M: Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 53:382–385. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Shan H, Qinglin Z, Fengjun X, Yuxin L, Xiaochen C and Yuan H: Reversal of multidrug resistance of KBV200 cells by triterpenoids isolated from Poria cocos. Planta Med. 78:428–433. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Lu C, Cai D and Ma J: Pachymic acid sensitizes gastric cancer cells to radiation therapy by upregulating bax through hypoxia. Am J Chin Med. 46:875–890. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Lian P, Liu Y and Xu K: Pachymic acid inhibits tumorigenesis in gallbladder carcinoma cells. Int J Clin Exp Med. 8:17781–17788. 2015.PubMed/NCBI | |
|
Gao AH, Zhang L, Chen X, Chen Y, Xu ZZ, Liu YN and Zhang H: Inhibition of ovarian cancer proliferation and invasion by pachymic acid. Int J Clin Exp Pathol. 8:2235–2241. 2015.PubMed/NCBI | |
|
Ling H, Zhang Y, Ng KY and Chew EH: Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat. 126:609–620. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Hong R, Shen MH, Xie XH and Ruan SM: Inhibition of breast cancer metastasis via PITPNM3 by pachymic acid. Asian Pac J Cancer Prev. 13:1877–1880. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Cheng S, Eliaz I, Lin J, Thyagarajan-Sahu A and Sliva D: Triterpenes from Poria cocos suppress growth and invasiveness of pancreatic cancer cells through the downregulation of MMP-7. Int J Oncol. 42:1869–1874. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Medzhitov R: Origin and physiological roles of inflammation. Nature. 454:428–435. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Cuéllar MJ, Giner RM, Recio MC, Just MJ, Máñez S and Ríos JL: Two fungal lanostane derivatives as phospholipase A2 inhibitors. J Nat Prod. 59:977–979. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Prieto JM, Recio MC, Giner RM, Máñez S, Giner-Larza EM and Ríos JL: Influence of traditional Chinese anti-inflammatory medicinal plants on leukocyte and platelet functions. J Pharm Pharmacol. 55:1275–1282. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Li FF, Yuan Y, Liu Y, Wu QQ, Jiao R, Yang Z, Zhou MQ and Tang QZ: Pachymic acid protects H9c2 cardiomyocytes from lipopolysaccharide-induced inflammation and apoptosis by inhibiting the extracellular signal-regulated kinase 1/2 and p38 pathways. Mol Med Rep. 12:2807–2813. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Cuélla MJ, Giner RM, Recio MC, Just MJ, Mañez S and Rios JL: Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chem Pharm Bull (Tokyo). 45:492–494. 1997.PubMed/NCBI View Article : Google Scholar | |
|
Yasukawa K, Kaminaga T, Kitanaka S, Tai T, Nunoura Y, Natori S and Takido M: 3beta-p-Hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry. 48:1357–1360. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Giner EM, Máñez S, Recio MC, Giner RM, Cerdá-Nicolás M and Ríos JL: In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids. Planta Med. 66:221–227. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Feng Z, Shi H, Liang B, Ge T, Cai M, Liu F, Huang K, Wen J, Chen Q and Ge B: Bioinformatics and experimental findings reveal the therapeutic actions and targets of pachymic acid against cystitis glandularis. Biofactors. 47:665–673. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Li JY, Wu HX and Yang G: Pachymic acid improves survival and attenuates acute lung injury in septic rats induced by cecal ligation and puncture. Eur Rev Med Pharmacol Sci. 21:1904–1910. 2017.PubMed/NCBI | |
|
Gui Y, Sun L, Liu R and Luo J: Pachymic acid inhibits inflammation and cell apoptosis in lipopolysaccharide (LPS)-induced rat model with pneumonia by regulating NF-κB and MAPK pathways. Allergol Immunopathol (Madr). 49:87–93. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Cai ZY, Sheng ZX and Yao H: Pachymic acid ameliorates sepsis-induced acute kidney injury by suppressing inflammation and activating the Nrf2/HO-1 pathway in rats. Eur Rev Med Pharmacol Sci. 21:1924–1931. 2017.PubMed/NCBI | |
|
Younis NN, Mohamed HE, Shaheen MA, Abdelghafour AM and Hammad SK: Potential therapeutic efficacy of pachymic acid in chronic kidney disease induced in rats: Role of Wnt/β-catenin/renin-angiotensin axis. J Pharm Pharmacol. 74:112–123. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Huang YC, Chang WL, Huang SF, Lin CY, Lin HC and Chang TC: Pachymic acid stimulates glucose uptake through enhanced GLUT4 expression and translocation. Eur J Pharmacol. 648:39–49. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Chen B, Zhang J, Han J, Zhao R, Bao L, Huang Y and Liu H: Lanostane triterpenoids with glucose-uptake-stimulatory activity from peels of the cultivated edible mushroom Wolfi Poria cocos. J Agric Food Chem. 67:7348–7364. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Li TH, Hou CC, Chang CL and Yang WC: Anti-Hyperglycemic properties of crude extract and triterpenes from Poria cocos. Evid. Based Complement. Alternat Med. 2011(128402)2011.PubMed/NCBI View Article : Google Scholar | |
|
Yang Z, Du R, Chang A, Zhang J and Li Q: The in vitro anti-biofilm activity of the etoac extract of Poria cocos against Escherichia coli. Asian J Pharma Res Deve. 1:152–156. 2013. | |
|
Singh A and Zhao K: Treatment of insomnia with traditional Chinese herbal medicine. Int Rev Neurobiol. 135:97–115. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Shah VK, Na SS, Chong MS, Woo JH, Kwon YO, Lee MK and Oh KW: Poria cocos ethanol extract and its active constituent, pachymic acid, modulate sleep architectures via activation of GABAA-ergic transmission in rats. J Biomed Res. 16:84–92. 2015. | |
|
Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, Li CY and Li CJ: Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 46:1650–1667. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jiang GP, Liao YJ, Huang LL, Zeng XJ and Liao XH: Effects and molecular mechanism of pachymic acid on ferroptosis in renal ischemia reperfusion injury. Mol Med Rep. 23(63)2021.PubMed/NCBI View Article : Google Scholar | |
|
Lee JH, Lee YJ, Shin JK, Nam JW, Nah SY, Kim SH, Jeong JH, Kim Y, Shin M, Hong M, et al: Effects of triterpenoids from Poria cocos Wolf on the serotonin type 3A receptor-mediated ion current in Xenopus oocytes. Eur J Pharmacol. 615:27–32. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Eom S, Kim YS, Lee SB, Noh S, Yeom HD, Bae H and Lee JH: Molecular determinants of α3β4 nicotinic acetylcholine receptors inhibition by triterpenoids. Biol Pharm Bull. 41:65–72. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang F, Zhang XF, Wang BC, Liu HY, Li CY, Liu ZH, Zhang GW, Lü H, Chi C and Wang F: Pachymic acid, a novel compound for anti-rejection: Effect in rats following cardiac allograft transplantation. Chin Med J (Engl). 122:2898–2902. 2009.PubMed/NCBI | |
|
Lee SG and Kim MM: Pachymic acid promotes induction of autophagy related to IGF-1 signaling pathway in WI-38 cells. Phytomedicine. 36:82–87. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Arun S, Sampath V, Mahalaxmi S and Rajkumar K: A comparative evaluation of the effect of the addition of pachymic acid on the cytotoxicity of 4 different root canal sealers-an in vitro study. J Endod. 43:96–99. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kamalakannan Preethi O, Sampath V, Ravikumar N and Mahalaxmi S: Comparative evaluation of physicochemical properties and apical sealing ability of a resin sealer modified with Pachymic Acid. Eur Endod J. 5:23–27. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Matsubara Y, Matsumoto T, Koseki J, Kaneko A, Aiba S and Yamasaki K: Inhibition of human kallikrein 5 protease by triterpenoids from natural sources. Molecules. 22(1829)2017.PubMed/NCBI View Article : Google Scholar | |
|
Kim JH, Sim HA, Jung DY, Lim EY, Kim YT, Kim BJ and Jung MH: Poria cocus Wolf extract ameliorates hepatic steatosis through regulation of lipid metabolism, inhibition of ER stress, and activation of autophagy via AMPK activation. Int J Mol Sci. 20(4801)2019.PubMed/NCBI View Article : Google Scholar | |
|
Fu XP, Xu L, Fu BB, Wei KN, Liu Y, Liao BQ, He SW, Wang YL, Chen MH, Lin YH, et al: Pachymic acid protects oocyte by improving the ovarian microenvironment in polycystic ovary syndrome mice. Biol Reprod. 103:1085–1098. 2020.PubMed/NCBI View Article : Google Scholar | |
|
He Y, Zhong JH, Wei XD, Huang CY, Peng PL, Yao J, Song XS, Fan WL and Li GC: Pachymic acid ameliorates pulmonary hypertension by regulating Nrf2-Keap1-ARE pathway. Curr Med Sci. 42:56–67. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Li W, Wang C, Zhang M, Yuan Y, Zhang Z, Liu X, Zhang F and Wu Y: Pachymic acid protects against kidney injury in mice with diabetic nephropathy by inhibiting the PI3K/AKT pathway. Trop J Pharm Res. 20:2539–2544. 2021. | |
|
Younis NN, Salama A, Shaheen MA and Eissa RG: Pachymic acid attenuated doxorubicin-induced heart failure by suppressing miR-24 and preserving cardiac junctophilin-2 in rats. Int J Mol Sci. 22(10710)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ling Y, Chen M, Wang K, Sun Z, Li Z, Wu B and Huang C: Systematic screening and characterization of the major bioactive components of Poria cocos and their metabolites in rats by LC-ESI-MS(n). Biomed Chromatogr. 26:1109–1117. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Zheng Y and Yang XW: Absorption and transport of pachymic acid in the human intestinal cell line Caco-2 monolayers. Zhong Xi Yi Jie He Xue Bao. 6:704–710. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Alatengqimuge Y, Yang XW, Zheng Y, Ma L and Lu W: LC analysis and pharmacokinetic study of pachymic acid after intravenous administration to rats. Chroma. 67:807–811. 2008. | |
|
Wang FY, Lv WS and Han L: Determination and pharmacokinetic study of pachymic acid by LC-MS/MS. Biol Pharm Bull. 38:1337–1344. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Guo H, Yan F, Yuan S, Li S, Zhu P, Chen W, Peng C and Peng D: An UPLC-Q-Orbitrap method for pharmacokinetics and tissue distribution of four triterpenoids in rats after oral administration of Poria cocos ethanol extracts. J Pharm Biomed Anal. 203(114237)2021.PubMed/NCBI View Article : Google Scholar | |
|
Ding B, Ji X, Sun X, Zhang T and Mu S: In vitro effect of pachymic acid on the activity of Cytochrome P450 enzymes. Xenobiotica. 50:913–918. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang J, Liu L, Li H and Zhang B: Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism. Pharm Biol. 59:1256–1259. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Staton CA, Reed MW and Brown NJ: A critical analysis of current in vitro and in vivo angiogenesis assays. Int J Exp Path. 90:195–221. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Saeidnia S, Manayi A and Abdollahi M: From in vitro experiments to in vivo and clinical studies; pros and cons. Curr Drug Discov Technol. 12:218–224. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Wang P, She G, Yang Y, Li Q, Zhang H, Liu J, Cao Y, Xu X and Lei H: Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents. Molecules. 17:4972–4985. 2012.PubMed/NCBI View Article : Google Scholar |
